This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.62% per year. These returns cover a period from January 1, 1988 through June 2, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Do Options Traders Know Something About Veeva Systems Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to VEEV stock based on the movements in the options market lately.
VEEVPositive Net Change
medical-devices
ECL Stock Gains Following Latest Launch to Boost Data Center Cooling
by Zacks Equity Research
Ecolab's 3D TRASAR technology expands its cooling solutions, aiming to optimize data centers and cut resource demand.
ECLPositive Net Change CORPositive Net Change HQYPositive Net Change ITGRNegative Net Change
medical medical-devices
HIMS' Buyouts Fuel International Expansion & Digital Health Innovation
by Zacks Equity Research
Hims & Hers accelerates European growth with new ZAVA acquisition, adding localized care and lab testing innovation.
TDOCNegative Net Change AMWLNegative Net Change HIMSPositive Net Change
medical medical-devices
Here's Why You Should Add PacBio Stock to Your Portfolio Now
by Zacks Equity Research
PACB benefits from strong first-quarter results, product innovation, and cost cuts to offset sales cycle delays and drive 2025 growth.
ANGOPositive Net Change CVSPositive Net Change PACBPositive Net Change ITGRNegative Net Change
medical medical-devices
Doximity Declines 4.4% in a Month: How to Play the Stock Now?
by Indrajit Bandyopadhyay
DOCS slips 4.4% in a month despite strong Q4 results, margin gains and raised guidance -- is there a buying opportunity?
VEEVPositive Net Change TDOCNegative Net Change IQVNegative Net Change DOCSPositive Net Change
medical medical-devices
Hudson Technologies (HDSN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
HDSNPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy SES AI Corporation (SES) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
SESNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Intuitive Surgical's da Vinci 5: Gaining Precision, Power and Potential
by Indrajit Bandyopadhyay
ISRG's da Vinci 5 is gaining momentum with key innovations like Force Feedback and strong Q1 placements boosting adoption.
SYKPositive Net Change ISRGPositive Net Change GMEDNegative Net Change
medical medical-devices
Should You Continue to Hold EXAS Sciences Stock in Your Portfolio?
by Zacks Equity Research
EXAS rides on strong Cologuard and Oncotype DX growth, but rising costs and high debt may test its staying power.
CORPositive Net Change PAHCPositive Net Change EXASNegative Net Change HIMSPositive Net Change
medical medical-devices
CVS Health Advances Digital Strategy: Is It the Next Revenue Pillar?
by Moumi Mondal
CVS unveils a $20B digital strategy to tackle healthcare gaps and reshape consumer health experiences.
CAHPositive Net Change CVSPositive Net Change WBANegative Net Change
medical medical-devices
HIMS Stock Falls Despite Latest Deal to Expand International Footprint
by Zacks Equity Research
Hims & Hers is set to acquire ZAVA to launch in Germany, France and Ireland, deepening its personalized digital health push.
CORPositive Net Change HQYPositive Net Change ITGRNegative Net Change HIMSPositive Net Change
medical medical-devices
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
by Zacks Equity Research
FMS continues to gain traction on the back of acquisitions & partnerships. A tough regulatory environment raises concerns.
ANGOPositive Net Change CVSPositive Net Change FMSNegative Net Change ITGRNegative Net Change
medical medical-devices
HealthEquity Stock Gains as Q1 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
HQY surpasses fiscal first-quarter revenue expectations on robust HSA growth. The company also updates its fiscal 2026 guidance.
ANGOPositive Net Change CVSPositive Net Change HQYPositive Net Change ITGRNegative Net Change
earnings medical medical-devices
Profit From the Silver Tsunami: Must-Watch Senior Care & Aging Stocks
by Urmimala Biswas
BSX, ABBV, AMGN and DXCM are tapping into the aging boom with cutting-edge tech, chronic care drugs and senior-focused innovations.
BSXPositive Net Change AMGNPositive Net Change DXCMNegative Net Change ABBVNegative Net Change CTREPositive Net Change CHCTPositive Net Change
biotechnology biotechs healthcare medical medical-devices pharmaceuticals
Emerging Markets Power Boston Scientific: Will the Growth Trend Continue?
by Sridatri Sarkar
BSX posts solid Q1 sales growth in emerging markets, reinforcing their role in the company's long-term global strategy.
ABTPositive Net Change BSXPositive Net Change MDTPositive Net Change
medical medical-devices
Hologic Navigates Breast Health Slump: Is the Growth Thesis Intact?
by Zacks Equity Research
HOLX weathers Breast Health softness with rising service revenues, the Endomag acquisition and new tech on the horizon.
BDXNegative Net Change HOLXNegative Net Change GEHCNegative Net Change
medical medical-devices
Doximity Rides on Telehealth Demand: Will This Drive Sales Further?
by Indrajit Bandyopadhyay
DOCS posts strong Q4 revenue growth and record user engagement as demand for telehealth and AI tools hits new highs.
HQYPositive Net Change TDOCNegative Net Change DOCSPositive Net Change
medical medical-devices
Should You Continue to Hold Labcorp Stock in Your Portfolio?
by Zacks Equity Research
LH's growth focus and financial strength look promising, but can it navigate rising competition and macro headwinds?
LHPositive Net Change CORPositive Net Change PAHCPositive Net Change HIMSPositive Net Change
medical medical-devices
Hyperfine Stock Rises After FDA Clears Next-Gen Swoop MRI System
by Zacks Equity Research
HYPR secures FDA clearance for its next-gen Swoop system, advancing bedside MRI tech and reinforcing its mission to revolutionize accessible neuroimaging.
ANGOPositive Net Change CVSPositive Net Change ITGRNegative Net Change HYPRPositive Net Change
medical medical-devices
SOLV's Strong Q1 Signals Turnaround: Is the Stock Worth Betting Now?
by Zacks Equity Research
Solventum beats Q1 estimates, raises guidance, and powers ahead with transformation despite looming tariff headwinds.
BDXNegative Net Change HSICPositive Net Change STENegative Net Change SOLVPositive Net Change
medical medical-devices
Should You Buy Sterling Infrastructure (STRL) After Golden Cross?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
STRLPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Buy These 4 Stocks With Solid Net Profit Margins to Enhance Return
by Anirudha Bhagat
Boost your portfolio with NOMD, NGS, DAVE and ATGE, each showing strong net profit margins and rising EPS estimates.
DAVEPositive Net Change NGSNegative Net Change NOMDNegative Net Change ATGEPositive Net Change
finance medical medical-devices oil-energy
QGEN Stock to Gain From Expanding Oncology Portfolio via New Alliances
by Zacks Equity Research
QIAGEN expands the oncology portfolio with new MRD testing alliances, setting the stage for personalized cancer care and stock growth.
QGENNegative Net Change CORPositive Net Change PAHCPositive Net Change HIMSPositive Net Change
medical medical-devices
Strattec Security (STRT) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
STRTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
TransMedics (TMDX) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
TMDXPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines